News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
666,737 Results
Type
Article (62448)
Company Profile (77)
Press Release (604202)
Multimedia
Podcasts (102)
Webinars (21)
Section
Business (174065)
Career Advice (2751)
Deals (32521)
Drug Delivery (116)
Drug Development (77119)
Employer Resources (154)
FDA (15165)
Job Trends (13949)
News (305839)
Policy (29126)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (2)
Academia (2913)
Academic (2)
Accelerated approval (35)
Adcomms (28)
Allergies (145)
Alliances (43264)
ALS (168)
Alzheimer's disease (1608)
Antibody-drug conjugate (ADC) (295)
Approvals (15441)
Artificial intelligence (536)
Autoimmune disease (167)
Automation (40)
Bankruptcy (291)
Best Places to Work (10853)
BIOSECURE Act (16)
Biosimilars (179)
Biotechnology (55)
Bladder cancer (157)
Brain cancer (61)
Breast cancer (632)
Cancer (4755)
Cardiovascular disease (398)
Career advice (2349)
Career pathing (40)
CAR-T (289)
CDC (48)
Celiac Disease (2)
Cell therapy (771)
Cervical cancer (35)
Clinical research (66092)
Collaboration (1664)
Company closure (5)
Compensation (725)
Complete response letters (59)
COVID-19 (2687)
CRISPR (97)
C-suite (923)
Cystic fibrosis (144)
Data (6189)
Decentralized trials (2)
Denatured (41)
Depression (138)
Diabetes (475)
Diagnostics (6490)
Digital health (45)
Diversity (13)
Diversity, equity & inclusion (40)
Drug discovery (249)
Drug pricing (185)
Drug shortages (25)
Duchenne muscular dystrophy (214)
Earnings (63328)
Editorial (60)
Employer branding (18)
Employer resources (138)
Events (98729)
Executive appointments (1042)
FDA (18301)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (9)
Frontotemporal dementia (23)
Funding (1470)
Gene editing (205)
Generative AI (46)
Gene therapy (575)
GLP-1 (910)
Government (4714)
Grass and pollen (7)
Guidances (381)
Healthcare (18266)
HIV (60)
Huntington's disease (40)
IgA nephropathy (80)
Immunology and inflammation (226)
Immuno-oncology (57)
Indications (111)
Infectious disease (2951)
Inflammatory bowel disease (193)
Inflation Reduction Act (13)
Influenza (118)
Intellectual property (251)
Interviews (531)
IPO (14908)
IRA (45)
Job creations (3420)
Job search strategy (1947)
JPM (62)
Kidney cancer (17)
Labor market (76)
Layoffs (592)
Leadership (37)
Legal (6473)
Liver cancer (84)
Longevity (13)
Lung cancer (632)
Lymphoma (369)
Machine learning (40)
Management (54)
Manufacturing (754)
MASH (164)
Medical device (13044)
Medtech (13096)
Mergers & acquisitions (18734)
Metabolic disorders (1213)
Multiple sclerosis (154)
NASH (13)
Neurodegenerative disease (309)
Neuropsychiatric disorders (87)
Neuroscience (2817)
Neurotech (1)
NextGen: Class of 2026 (6385)
Non-profit (4352)
Now hiring (21)
Obesity (552)
Opinion (295)
Ovarian cancer (162)
Pain (201)
Pancreatic cancer (227)
Parkinson's disease (278)
Partnered (33)
Patents (507)
Patient recruitment (515)
Peanut (60)
People (61270)
Pharmaceutical (19)
Pharmacy benefit managers (26)
Phase 1 (20828)
Phase 2 (29133)
Phase 3 (21274)
Pipeline (5270)
Policy (276)
Postmarket research (2471)
Preclinical (8853)
Press Release (67)
Prostate cancer (244)
Psychedelics (42)
Radiopharmaceuticals (281)
Rare diseases (832)
Real estate (6033)
Recruiting (66)
Regulatory (22342)
Reports (41)
Research institute (2468)
Resumes & cover letters (408)
Rett syndrome (28)
RNA editing (15)
RSV (70)
Schizophrenia (144)
Series A (242)
Series B (185)
Service/supplier (8)
Sickle cell disease (95)
Special edition (16)
Spinal muscular atrophy (155)
Sponsored (43)
Startups (3380)
State (1)
Stomach cancer (12)
Supply chain (87)
Tariffs (67)
The Weekly (59)
Vaccines (980)
Venture capital (78)
Weight loss (338)
Women's health (84)
Worklife (21)
Date
Last 7 days (522)
Last 30 days (2105)
Last 365 days (28253)
2026 (3780)
2025 (28677)
2024 (32271)
2023 (36330)
2022 (46608)
2021 (51560)
2020 (50713)
2019 (44762)
2018 (34056)
2017 (30712)
2016 (30059)
2015 (35435)
2014 (28372)
2013 (24951)
2012 (26211)
2011 (26452)
2010 (24930)
Location
Africa (886)
Alabama (85)
Alaska (6)
Arizona (240)
Arkansas (14)
Asia (39414)
Australia (7075)
California (10420)
Canada (3085)
China (1057)
Colorado (441)
Connecticut (447)
Delaware (331)
Europe (91990)
Florida (1576)
Georgia (350)
Hawaii (3)
Idaho (59)
Illinois (879)
India (67)
Indiana (481)
Iowa (22)
Japan (416)
Kansas (119)
Kentucky (39)
Louisiana (26)
Maine (75)
Maryland (1282)
Massachusetts (7352)
Michigan (335)
Minnesota (564)
Mississippi (6)
Missouri (137)
Montana (34)
Nebraska (26)
Nevada (113)
New Hampshire (77)
New Jersey (2897)
New Mexico (30)
New York (2845)
North Carolina (1418)
North Dakota (10)
Northern California (5032)
Ohio (322)
Oklahoma (23)
Oregon (42)
Pennsylvania (2059)
Puerto Rico (24)
Rhode Island (45)
South America (1187)
South Carolina (53)
South Dakota (1)
Southern California (4146)
Tennessee (170)
Texas (1667)
United States (37426)
Utah (324)
Vermont (1)
Virginia (259)
Washington D.C. (66)
Washington State (860)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
666,737 Results for "university of glasgow".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
LIB Therapeutics Announces Key Results from Presentations at 2025 European Atherosclerosis Society Meeting in Glasgow May 5-6
May 7, 2025
·
5 min read
Press Releases
Stellaromics Expands Pyxa™ 3D Spatial Transcriptomics Beta Program with Installation at Emory University School of Medicine
January 29, 2026
·
3 min read
Press Releases
First-of-its-kind Universal Clearance Establishes Maximum Regulatory Access to the Bezier Parametric Curve Spinal Rod System for Patients and Surgeons
February 5, 2026
·
2 min read
Press Releases
Zeon Corporation Makes Strategic Investment in Chemify to Accelerate Digital Chemistry Innovation and Drive Development of New Materials Through State-of-the-Art Automated Molecular Design and Synthesis
February 12, 2026
·
2 min read
Press Releases
Gilead Presents Full PURPOSE 2 Data Results for Twice-Yearly Lenacapavir for HIV Prevention at HIV Glasgow
November 13, 2024
·
13 min read
Press Releases
ViiV Healthcare expands on real-world data supporting use of long-acting therapies in diverse patient populations at HIV Glasgow
November 8, 2024
·
18 min read
Press Releases
Late-Breaking Clinical Data and Real-World Evidence Presented at HIV Glasgow as Gilead Extends Leadership Efforts Toward Ending the Epidemic
November 8, 2024
·
19 min read
Press Releases
Hemostemix Presents ACP-01 Data at University of Florida Grand Rounds: Highlights Strong Safety, Functional Gains, and Florida Access Pathway
Session led by neurosurgeon Dr. Fraser Henderson and Hemostemix CEO Thomas Smeenk for the University of Florida’s Department of Surgery, Division of Vascular Surgery & Endovascular Therapy (Gainesville)
November 13, 2025
·
10 min read
Precision-Panc Team Open the PRIMUS-006 Study, a Novel Combination of IMM-101, Gemcitabine and Pembrolizumab
The Precision-Panc team at the University of Glasgow, with their Co-Sponsor, NHS Greater Glasgow & Clyde, announced the opening of the Phase II PRIMUS-006 study evaluating IMM-101, a broad-spectrum immunomodulatory agent containing heat-killed, whole cell Mycobacterium obuense, in combination with gemcitabine and pembrolizumab as first-line treatment in patients with metastatic pancreatic cancer.
June 18, 2024
·
5 min read
Press Releases
University of Phoenix appoints Sheila Babendir as Dean of the College of Social and Behavioral Sciences
January 21, 2026
·
3 min read
1 of 66,674
Next
